Navigation Links
Personalizing prostate specific antigen testing may improve specificity, reduce biopsies
Date:4/15/2013

New York, NY, April 14, 2013 Genetic variants have been identified which can increase serum prostate specific antigen (PSA) concentrations and prostate cancer risk. A new study published in The Journal of Urology reports that correcting PSA levels for these genetic variants can have significant consequences, including avoiding unnecessary biopsies for some men and eliminating false complacency for others.

In this study of 964 healthy Caucasian men, correcting individual PSA levels for these genetic variants led to an 18.3 percent reduction in the number of men who initially had a measured serum PSA above the biopsy criteria, but whose adjusted PSA fell below the cutoff value. The latter group would have likely undergone what would have been an unnecessary biopsy. Conversely, genetic correction led to PSA levels moving from below threshold to above threshold for 3.4 percent of the men, thus sending out an alert for further investigation.

"If our results are validated, adjustment for the four PSA single nucleotide polymorphisms (SNPs) could potentially prevent up to 15 percent to 20 percent of prostate biopsies. Since it has been estimated that more than 1 million biopsies are performed in the United States annually, this could translate into 150,000 to 200,000 potentially unnecessary biopsies every year," says William J. Catalona, MD, professor of urology at the Feinberg School of Medicine of Northwestern University. In addition to cost savings, fewer biopsies mean fewer adverse outcomes, such as infection, sepsis, and hospitalization.

For 98 percent of the men, genetic adjustment of PSA levels did not change outcome. However, genetic correction was important for the 17 men who were reclassified as no longer meeting biopsy criteria of PSA 2.5 ng/ml or greater and the three whose condition was up classified. The results suggest that traditional single cutoff PSA screening levels of 2.5 ng/ml or greater or 4.0 ng/ml or greater should be personalized to reflect an individual's genetic make-up.

"If confirmed, this approach could potentially be used to tailor PSA screening, possibly reducing unnecessary biopsies and avoiding delay in performing necessary biopsies," concludes Dr. Catalona and his co-investigators.


'/>"/>

Contact: Linda Gruner
jumedia@elsevier.com
212-633-3923
Elsevier Health Sciences
Source:Eurekalert

Related medicine news :

1. Personalizing medicine: New American Chemical Society Prized Science video
2. Personalizing biologic treatment to individual patients with rheuatoid arthritis is cost-effective
3. Can Selenium Lower Risk of Advanced Prostate Cancer?
4. Counting copy numbers characterises prostate cancer
5. Prostate cancer treatment study changing the way doctors practice
6. Intermittent Hormone Treatment for Prostate Cancer Not the Best
7. Black Men Often Face Delays in Prostate Cancer Care: Study
8. York scientists discover driving force behind prostate cancer
9. Is Early Baldness in Blacks a Clue to Prostate Cancer?
10. Early-onset baldness in African-American men may be linked to prostate cancer
11. Dennis R. Hill MD Announces Launch of High Dose Rate Brachytherapy of Prostate Cancer Website
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2017)... ... May 20, 2017 , ... Pot. Reefer. Grass. Mary Jane. No matter what ... its attributes like never before. More than a map, new social marketplace Weedable ... strains, products – and for the first time – each other. A social marketplace ...
(Date:5/21/2017)... , ... May 21, 2017 , ... ... it's been longer than six months since you've seen a dentist, it's time ... per year and getting x-rays once per year. , Dental checkups are a ...
(Date:5/19/2017)... ... 19, 2017 , ... Springfield, Vermont-based law firm of Brady/Callahan has released a ... To Hire An Experienced Personal Injury Attorney, " the article offers insight for people ... the article says. if someone is injured due to another person's negligence, they ...
(Date:5/19/2017)... (PRWEB) , ... May 19, 2017 , ... As a ... knows the importance of prostate cancer screenings. Early detection of the disease, he ... of robotic surgery at Georgia Urology , stands alongside the Georgia Comprehensive Cancer ...
(Date:5/18/2017)... ... ... Dr. Kim Ross supports Stroke Awareness Month by now accepting new patients for ... and serious systemic health conditions including heart disease and stroke. Those with bleeding gums ... seeking treatment with Dr. Ross immediately may prevent bacteria from spreading. , While ...
Breaking Medicine News(10 mins):
(Date:5/4/2017)... , May 4, 2017  DarioHealth Corp. (NASDAQ: DRIO), ... and big data solutions, today announced that it is ... and STI Technologies Limited to lower diabetes healthcare costs ... STI,s innoviCares card, which is available throughout all provinces ... customers will be eligible for additional savings when shopping ...
(Date:5/3/2017)... ROCKVILLE, Md. , May 3, 2017 /PRNewswire/ ... revenue growth of nine percent next year and ... solid organ and hematopoietic stem cell (HSCT) or ... and donor. Molecular testing technologies are well-suited for this ... healthcare-only market research publisher Kalorama Information. The various ...
(Date:5/2/2017)... SYDNEY , May 2, 2017  George Clinical, ... Asia-Pacific region, and Vector Oncology, a ... research and data analytics, formally announced today that George ... immediately, the transaction has the dual purpose of ... scientifically led oncology trial delivery solutions throughout the ...
Breaking Medicine Technology: